Bruce Jackson
Stock Analyst at Benchmark
(1.04)
# 3,808
Out of 5,065 analysts
123
Total ratings
30%
Success rate
-19.56%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiates: Buy | $145 | $128.11 | +13.18% | 1 | Oct 10, 2025 | |
| CV CapsoVision | Initiates: Speculative Buy | $5 | $5.23 | -4.40% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.74 | +271.72% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.22 | +1,047.54% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.63 | +372.52% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $9.27 | +255.99% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.96 | +363.71% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $120.56 | -33.64% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.48 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $100.90 | -35.58% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.32 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $5.40 | +455.56% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.30 | +311.18% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.09 | +176.50% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.88 | +165.96% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $10.63 | +2,722.20% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $2.58 | +2,224.86% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.51 | +3,218.37% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.10 | +2,081.82% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.44 | +1,025.62% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.32 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $28.00 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.36 | +33,798.31% | 1 | Aug 8, 2022 |
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $128.11
Upside: +13.18%
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $5.23
Upside: -4.40%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.74
Upside: +271.72%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.22
Upside: +1,047.54%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.63
Upside: +372.52%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $9.27
Upside: +255.99%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.96
Upside: +363.71%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $120.56
Upside: -33.64%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.48
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $100.90
Upside: -35.58%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.32
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $5.40
Upside: +455.56%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.30
Upside: +311.18%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.09
Upside: +176.50%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $10.63
Upside: +2,722.20%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $2.58
Upside: +2,224.86%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.51
Upside: +3,218.37%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.10
Upside: +2,081.82%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.44
Upside: +1,025.62%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.32
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $28.00
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.36
Upside: +33,798.31%